Anthony Atala to RNA, Messenger
This is a "connection" page, showing publications Anthony Atala has written about RNA, Messenger.
Connection Strength
0.780
-
Atala A. Re: Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs and circRNAs with Associated Co-Expression and ceRNA Networks in Bladder Carcinoma. J Urol. 2017 01; 197(1):51-52.
Score: 0.505
-
Lu B, Javidi-Parsijani P, Makani V, Mehraein-Ghomi F, Sarhan WM, Sun D, Yoo KW, Atala ZP, Lyu P, Atala A. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing. Nucleic Acids Res. 2019 05 07; 47(8):e44.
Score: 0.151
-
Lyu P, Yoo KW, Yadav MK, Atala A, Aartsma-Rus A, Putten MV, Duan D, Lu B. Sensitive and reliable evaluation of single-cut sgRNAs to restore dystrophin by a GFP-reporter assay. PLoS One. 2020; 15(9):e0239468.
Score: 0.042
-
Chen W, Xie M, Yang B, Bharadwaj S, Song L, Liu G, Yi S, Ye G, Atala A, Zhang Y. Skeletal myogenic differentiation of human urine-derived cells as a potential source for skeletal muscle regeneration. J Tissue Eng Regen Med. 2017 02; 11(2):334-341.
Score: 0.027
-
Yamaleyeva LM, Guimaraes-Souza NK, Krane LS, Agcaoili S, Gyabaah K, Atala A, Aboushwareb T, Yoo JJ. Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury. Stem Cells Transl Med. 2012 May; 1(5):373-83.
Score: 0.023
-
Tian H, Bharadwaj S, Liu Y, Ma PX, Atala A, Zhang Y. Differentiation of human bone marrow mesenchymal stem cells into bladder cells: potential for urological tissue engineering. Tissue Eng Part A. 2010 May; 16(5):1769-79.
Score: 0.020
-
Schuch G, Machluf M, Bartsch G, Nomi M, Richard H, Atala A, Soker S. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood. 2002 Dec 15; 100(13):4622-8.
Score: 0.012